Top Markets
#1 Tutorial Tutorial +32.13%
#2 Official Trump Official Trump +30.85%
#3 Siacoin Siacoin +22.77%
#4 EXOD EXOD +22.08%
#5 Mubarak Mubarak +20.56%
#6 MowCat MowCat +18.58%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +18.51%
#8 Unit Pump Unit Pump +17.74%
#9 Pump.fun Pump.fun +17.74%
#10 Melania Meme Melania Meme +16.61%
Coin of the day
Tutorial Tutorial
Settings
Language
ENGLISH
Currency
USD
Theme
Kyongbo Pharmaceutical Co., Ltd Kyongbo Pharmaceutical Co., Ltd

Kyongbo Pharmaceutical Co., Ltd

214390
Rank in Stocks #22754
Established in 1987 and based in Asan, South Korea, Kyongbo Pharmaceutical Co.,... Established in 1987 and based in Asan, South Korea, Kyongbo Pharmaceutical Co., Ltd is a key player in the South Korean pharmaceutical market, primarily focusing on the production and distribution of active pharmaceutical ingredients (APIs). Its API offerings span general, cephalosporin, and anti-cancer categories. Beyond APIs, the company also supplies a range of finished pharmaceutical products, including prescription medications for anesthetic, cardiovascular, and digestive uses, as well as antibiotics, alongside its over-the-counter (OTC) drug portfolio. Kyongbo Pharmaceutical extends its reach internationally, exporting its goods to 30 countries worldwide. The company officially adopted its current name, Kyongbo Pharmaceutical Co., Ltd, in March 2002, having previously been known as Kyongbo Chemical Co. Ltd.
Share Price
$3.51
Last synced: 2026-08-21
Market Cap
$83.81M
Change (1 day)
-1.74%
Change (1 year)
-1.96%
Country
KR
Trade Kyongbo Pharmaceutical Co., Ltd (214390)

Category

Healthcare
Revenue for Kyongbo Pharmaceutical Co., Ltd (214390)
Revenue in Aug 2026 TTM: 0
According to Kyongbo Pharmaceutical Co., Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Kyongbo Pharmaceutical Co., Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN